Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (111-120 of 480) with videos related to

Pageof 48
Sort By:
Expert Opinion on Drug Safety|May 1, 2019
Analgesic treatments in people with dementia - how safe are they? A systematic reviewAne Erdal, Clive Ballard, Ipsit Vihang Vahia, et al.
Brain and Behavior|October 18, 2021
Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training?Mandy Roheger, Elke Kalbe, Anne Corbett, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2019
Alzheimer's Disease Progression in the 5×FAD Mouse Captured with a Multiplex Gene Expression ArrayAriana Gatt, David R Whitfield, Clive Ballard, et al.
Pharmacology, Biochemistry, and Behavior|August 5, 2003
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trialNicolette S L Perry, Chloe Bollen, Elaine K Perry, et al.
International Journal of Geriatric Psychiatry|July 7, 2018
Course of neuropsychiatric symptoms in dementia: 5-year longitudinal studyAudun Osland Vik-Mo, Lasse Melvaer Giil, Clive Ballard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2009
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort studyUwe Ehrt, Karl Broich, Jan Petter Larsen, et al.
Stroke|September 27, 2003
Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of ageClive Ballard, Elise Rowan, Sally Stephens, et al.
International Psychogeriatrics|June 25, 2025
Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approachJeffrey L Cummings, Kate Zhong, Clive Ballard, et al.
Journal of the Neurological Sciences|March 3, 2023
The impact of low dementia research funding on brain health for decision makers: A reflection on current health statisticsPeter Fusdahl, Jeffrey Cummings, Clive Ballard, et al.
Annals of Neurology|October 22, 2005
Neuropathology of dementia in Parkinson's disease: a prospective, community-based studyDag Aarsland, Robert Perry, Andrew Brown, et al.
Pageof 48

Showing results (111-120 of 480) with videos related to

Sort By:
Pageof 48
Expert Opinion on Drug Safety|May 1, 2019
Analgesic treatments in people with dementia - how safe are they? A systematic reviewAne Erdal, Clive Ballard, Ipsit Vihang Vahia, et al.
Brain and Behavior|October 18, 2021
Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training?Mandy Roheger, Elke Kalbe, Anne Corbett, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2019
Alzheimer's Disease Progression in the 5×FAD Mouse Captured with a Multiplex Gene Expression ArrayAriana Gatt, David R Whitfield, Clive Ballard, et al.
Pharmacology, Biochemistry, and Behavior|August 5, 2003
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trialNicolette S L Perry, Chloe Bollen, Elaine K Perry, et al.
International Journal of Geriatric Psychiatry|July 7, 2018
Course of neuropsychiatric symptoms in dementia: 5-year longitudinal studyAudun Osland Vik-Mo, Lasse Melvaer Giil, Clive Ballard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2009
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort studyUwe Ehrt, Karl Broich, Jan Petter Larsen, et al.
Stroke|September 27, 2003
Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of ageClive Ballard, Elise Rowan, Sally Stephens, et al.
International Psychogeriatrics|June 25, 2025
Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approachJeffrey L Cummings, Kate Zhong, Clive Ballard, et al.
Journal of the Neurological Sciences|March 3, 2023
The impact of low dementia research funding on brain health for decision makers: A reflection on current health statisticsPeter Fusdahl, Jeffrey Cummings, Clive Ballard, et al.
Annals of Neurology|October 22, 2005
Neuropathology of dementia in Parkinson's disease: a prospective, community-based studyDag Aarsland, Robert Perry, Andrew Brown, et al.
Pageof 48